The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022

The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022

Cardiovascular disease (CVD) has become a huge challenge for the global public health system due to its high morbidity, mortality and severe economic burden. In recent years, angiotensin receptor neprilysin inhibitor (ARNI), a new class of drugs, has shown good therapeutic effects on CVD patients in...

Full description

Bibliographic Details
Main Authors: Xia Xu, Yumeng Li, Shuqing Shi, Jiayu Lv, Yajiao Wang, Haoran Zheng, Xinxin Mao, Huaqin Wu, Bingxuan Zhang, Qingqiao Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
angiotensin receptor neprilysin inhibitor
cardiovascular disorders
CiteSpace
research hotspots
mapping knowledge domains
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.899235/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.899235/full

Similar Items